Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.55
-0.2500-3.68%
Volume:292.17K
Turnover:1.95M
Market Cap:663.92M
PE:-9.22
High:6.81
Open:6.80
Low:6.53
Close:6.80
Loading ...

Day One Biopharmaceuticals Files Initial Ownership Statement; Michael Vasconcelles Named as Head of Research and Development

Reuters
·
19 Jun

Day One Biopharmaceuticals Inc. Appoints Michael Vasconcelles, M.D., as Head of Research and Development to Lead Pipeline Growth

Reuters
·
10 Jun

Day One Appoints Michael Vasconcelles, M.d., as Head of Research and Development

THOMSON REUTERS
·
10 Jun

Day One Biopharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
04 Jun

Chief Commercial Officer Lauren Merendino Reports Disposal of Common Shares in Day One Biopharmaceuticals Inc

Reuters
·
20 May

Adam Dubow, General Counsel, Reports Disposal of Day One Biopharmaceuticals Inc. Common Shares

Reuters
·
20 May

York Charles N II, COO, CFO and Secretary, Reports Disposal of Common Shares of Day One Biopharmaceuticals Inc

Reuters
·
20 May

Stock Track | Day One Biopharmaceuticals Soars 7.58% as Needham Reaffirms Buy Rating Despite Seasonal Challenges

Stock Track
·
07 May

Stock Track | Day One Biopharmaceuticals Soars 5.29% Pre-market as Needham Reaffirms Buy Rating

Stock Track
·
07 May

Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed

TIPRANKS
·
07 May

Day One Biopharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Day One Biopharmaceutical Q1 EPS $(0.35) Beats $(0.44) Estimate, Sales $30.76M Beat $30.24M Estimate

Benzinga
·
07 May

BRIEF-Day One Biopharmaceuticals Q1 EPS USD -0.35 Vs. IBES Estimate USD -0.44

Reuters
·
07 May

Q1 2025 American International Group Inc Earnings Call

Thomson Reuters StreetEvents
·
03 May

Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

GlobeNewswire
·
22 Apr

BofA Adjusts Price Target on Day One Biopharmaceuticals to $21 From $24, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Day One Biopharmaceuticals price target lowered to $21 from $24 at BofA

TIPRANKS
·
17 Apr

Bank of America Securities Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)

TIPRANKS
·
17 Apr

UNDER ARMOUR APPOINTS DAWN N. FITZPATRICK, EUGENE D. SMITH, AND ROBERT J. SWEENEY TO ITS BOARD OF DIRECTORS

PR Newswire
·
15 Apr

Day One Biopharm Price Target Maintained With a $36.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr